The NHS in London is radically changing the way that cancer care and services are being delivered.
These changes, put forward by clinicians including GPs and nurses and specialists at acute trusts, have the potential to save up to 1,000 lives every year in London. Just as importantly, they aim to improve the experience of every patient accessing cancer services in the capital and ensure the care delivered is of a consistently high standard.
London Heath Programmes is facilitating this change which includes the development of 2 Integrated Cancer Systems (ICSs) to improve care along the entire patient pathway.
Commissioners and providers come together to discuss progress of the implementation of these changes at Joint Development Groups for each ICS area, which patient representatives also attend.
Overseeing this work at London Health Programmes is Dr Chris Harrison, medical director of The Christie, Manchester’s specialist cancer hospital, and Rachel Tyndale, former Chief Executive of North Central London sector, who were appointed by NHS London to lead the transformation of cancer services in the capital.
Our frequently asked questions factsheet provides an overview and rationale for the case for change of cancer services in London, and the subsequent development and implementation of Integrated Cancer Systems (ICSs) and revised commissioning approaches to deliver this change. It gives a clear process with specific detail on the following areas:
- The background to the project
- The concept and design
- ICS development and implementation
- ICS commissioning
- ICS governance and information governance
- Future development
To read the full frequently asked questions factsheet ICS Q&A final